"Designing Growth Strategies is in our DNA"

Monitoring Bands Market Size, Share, and Industry Analysis By Material (Polyester, Nylon, and Others), By Application (Antepartum and Intrapartum), By End-user (Hospitals, Specialty Clinics and Gynecology Centers, and Others), and Regional Forecast, 2025-2032

Region : Global | Report ID: FBI110799 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global fetal monitoring bands market is witnessing significant growth due to an increasing awareness regarding the safety of maternal and fetal health. These bands are responsible for monitoring the fetus’s health during pregnancy and the labor period.

The bands are constructed with the specialized types of fibers, such as soft woven polyester, that stretches easily and fit different body sizes. The fetal monitoring bands record the fetus's heart rate and the mother's uterine contractions. These bands can be considered to be a great alternative to fetal monitoring belts and straps.

  • As per data provided by the Arizona Department of Health Services (ADHS) in January 2022, the ADHS collaborated with the Arizona Hospital and Healthcare Association to celebrate Maternal Health Awareness Day in January 2022. Through such occasions, the ADHS helps women and families to increase the likelihood of healthy births.

Fetal Monitoring Bands Market Driver

Growing Cases of Preterm Births to Drive Industry Expansion

The significant growth of the fetal monitoring bands market is largely due to the increasing global prevalence of the preterm births. As the preterm birth rates rise, there is a greater need for the early and precise fetal health monitoring. Fetal monitoring bands provide a non-invasive, continuous, and real-time tracking solution, facilitating the early detection of potential complications and improving maternal and fetal health outcomes. This trend highlights the need for novel, ground-breaking, and reliable fetal monitoring solutions.

  • For instance, as per data provided by the World Health Organization (WHO) in May 2023, an estimated 13.4 million babies were born preterm in 2020 (before 37 completed weeks of gestation). As per the same source, preterm birth complications are the primary cause of death among children under five years of age, responsible for approximately 900,000 deaths in 2019.

According to data provided by the Centers for Disease Control and Prevention (CDC), the rate of preterm births increased slightly between 2022 and 2023. The terminologies mentioned above are defined as preterm ((under 37 weeks), late preterm (34–36 weeks), and early preterm (under 34 weeks).

Fetal Monitoring Bands Market Restraint

High Cost of Fetal Monitoring Bands May Restrict Market Growth

One of the major restraining factors for the global fetal monitoring bands market is the expensive nature of advanced monitoring solutions, along with restricted availability in low- and middle-income countries. The market penetration of these advanced devices depends greatly on their affordability and availability. The limited adoption of advanced monitoring systems in areas with limited healthcare budgets and infrastructure impacts the global market growth.

  • For instance, the AltroCare fetal monitoring bands are priced between USD 120 and USD 150. These bands are expensive and unaffordable for individuals in low-income countries.

Fetal Monitoring Bands Market Opportunity

Advancements in Technology and Expansion into Emerging Markets

The surge in expansion initiatives into the emerging markets, technological advancements in the fetal monitoring bands, and the increasing use of mobile health (mHealth) applications create a noteworthy opportunity in the market. Advances in the wireless technologies and the incorporation of artificial intelligence (AI) for the forecasting analytics in the fetal monitoring could transform prenatal care by providing more precise, easy-to-use, and available options.

  • For example, major market players such as BeoCare, Inc., EME Company, Inc., CooperSurgical Inc., and AltroCare are present in the U.S., and are engaged in providing fetal monitoring products inside the U.S. These companies have a limited presence in emerging nations of the Middle East and Africa. With increasing awareness regarding fetal monitoring during pregnancy and labor in emerging countries, these players can provide fetal monitoring products in these nations. This can be considered as a significant opportunity for market players operating in the fetal monitoring bands market.

Key Insights

The report covers the following key insights:

  • Prevalence of Preterm Births, By Key Countries, 2022/2023
  • New Product Launches, By Key Players
  • Key Industry Developments (Mergers, Acquisitions, and Partnerships)
  • Impact of COVID-19 on the Market 

Segmentation

By Material

By Application

By End-user

By Geography

  • Polyester
  • Nylon
  • Others
  • Antepartum
  • Intrapartum
  • Hospitals
  • Specialty Clinics and Gynecology Centers
  • Others
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Analysis by Material

Based on material, the market is divided into polyester, nylon, and others.

The polyester segment is anticipated to grow at a significant CAGR from 2024-2032. The growth of the segment is mainly attributed to the availability of a large number of polyester fetal monitoring bands in the global market.

  • For instance, a large number of products such as BARI-BAND bariatric toco abdominal bands provided by Utah Medical Products, Inc. and Fetal Monitor Belly Band provided by BeoCare, Inc. are available in polyester material.

Analysis by Application

By application, the market is subdivided into antepartum and intrapartum.

The intrapartum segment is expected to grow at a substantial CAGR during the forecast period. The intrapartum sector is experiencing significant market expansion, with a focus on monitoring throughout the labor and delivery. This stage is crucial for ongoing monitoring to avoid potential issues, emphasizing the significance of this section. The segment growth is due to a strong, focused approach to decreasing perinatal morbidity and mortality, as well as an increased recognition of the importance of intrapartum monitoring in handling obstetric emergencies.

  • For instance, as per data provided by the National Center for Biotechnology Information (NCBI) in December 2021, nearly four million births occur in the U.S. per year. More than 85.0% are monitored with electronic fetal monitoring (EFM) during labor to protect the well-being of the fetus/neonate.

Analysis by End-user

Based on end-user, the market is categorized into hospitals, specialty clinics and gynecology centers, and others.

The hospital segment is expected to grow at a significant CAGR from 2024 to 2032. The growth of the segment is largely due to the fact that hospitals are crucial in providing ongoing and crucial monitoring, which is vital for the health of both the fetus and the mother. Hospitals use these monitoring devices extensively as primary care centers for childbirth to allow real-time observation and quick medical intervention, which are essential for obstetric care. The significant uptake of this technology in hospitals is fueled by the need for accurate, ongoing surveillance to safeguard the health and welfare of both the mother and the baby.

  • For instance, in February 2024, Cromwell Hospital announced the opening of the London Centre for gynecology care in the U.K. This center would provide comprehensive diagnostic services for all gynecological conditions using the latest technology.

Regional Analysis

To gain extensive insights into the market, Download for Customization

By region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a significant share of the global fetal monitoring bands in 2023. The growth of the market in this region is primarily due to the presence of its advanced healthcare infrastructure, increased awareness of prenatal care, and significant investments in maternal health technology. The region's constant innovation and key industry players contribute to the market's success, solidifying North America's position as a leader in the sector.

  • For example, the majority of fetal monitoring band manufacturers such as Medline Industries, LP, ASP Global, BeoCare, Inc., and AltroCare are present in the U.S.

Europe accounted for a substantial market share in 2023. The significant investments in healthcare, robust government backing for maternal health, and a considerable demand for non-invasive prenatal monitoring are some of the factors anticipated to drive market growth in this region during the forecast period.

  • For example, as per data provided by the Crown in March 2024, around GBP 35.0 (USD 37.9) million was invested by the government of England to enhance the maternity safety by hiring more midwives and providing specialized training to thousands of healthcare workers.

Furthermore, the Asia Pacific fetal monitoring bands market is expected to grow at a notable CAGR during the forecast period. The Asia Pacific region is experiencing growth due to advancements in the healthcare infrastructure and enhanced maternal health awareness, particularly in countries with large populations such as China and India, indicating significant market opportunities.

Key Players Covered

The global fetal monitoring bands market is semi-fragmented, with the presence of a few players accounting for a larger proportion.

The report includes the profiles of the following key players:

  • ASP Global (U.S.)
  • BeoCare, Inc. (U.S.)
  • Medline Industries, LP. (U.S.)
  • EME Company, Inc (U.S.)
  • CooperSurgical Inc. (The Cooper Companies, Inc.) (U.S.)
  • Kerma Medical Products (U.S.)
  • AltroCare (U.S.)
  • NUVO Inc. (U.S.)

Key Industry Developments

  • In June 2021, Nuvo Group announced that it received clearance from the U.S. Food and Drug Administration (FDA) to add a new uterine activity module that provides the capability for remote monitoring of uterine activity (UA).
  • In March 2020, Nuvo Group, a Tel Aviv-based medical device company, received the U.S. Food and Drug Administration (FDA) approval for its wearable sensor band, which can monitor fetal and maternal heart rate data.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann